In industrialized countries, certain types of cancer, most notably, breast and prostate, are more frequent than in poorly developed nations. This high cancer frequency is not explained by any of the conventional causes. Within the past decade, numerous reports have appeared that link light at night with an elevated cancer risk. The three major consequences of light at night are sleep deprivation, chronodisruption, and melatonin suppression. Each of these individually or in combination may contribute to the reported rise in certain types of cancer. In this article, the potential mechanisms underlying the basis of the elevated cancer risk are briefly discussed. Finally, if cancer is a consequence of excessive nighttime light, it is likely that other diseases/conditions may also be exaggerated by the widespread use of light after darkness onset.
Introduction
The problem is that humans are living a 21st-century life style with an ancient genome. In this new stetting, the photoperiodic environment is changing so rapidly that we cannot physiologically adapt to the changes. With increased urbanization and the invention of the artificial light source in 1879, light use after darkness onset has risen exponentially, especially since the mid 20th century. This has led to severe and repeated contamination of the daily dark period with what is referred to as light pollution, which comes from a variety of sources. Meanwhile, our biological clock, which evolved over hundreds of thousands of years and which relied on regular alternating light and dark periods, has been unable to adjust to this rapid change in the photoperiodic environment.
During evolution, humans, and in fact all vertebrates, developed a set of central pacemaker neurons in the basal hypothalamus now known as the biological clock (suprachiasmatic nuclei [SCN]), which were entrained by the regular repeating periods of light and uninterrupted darkness. 1, 2 The SCN, via both humoral and neural signaling outputs, are designed to control circadian rhythms throughout the organism and keep them properly aligned with the rising and setting of the sun. These regularly repeating organismal and cellular cycles provide for precise control of molecular events and, therefore, optimal function and health. The opprobrious attack on these pacemakers with light at night causes disturbances of clock processes referred to circadian disruption, biological rhythm desynchronization, or chronodisruption. [3] [4] [5] Considering the repeated perturbations of these basic molecular rhythms within cells, it should not be surprising that eventually some pathophysiological processes would become manifested. One manifestation that may be a result of the persistent disturbance of these very basic cycles appears to be abnormal cellular growth, that is, cancer. [6] [7] [8] [9] [10] 
Contamination of Night With Light
The exposure of any species, including humans, to artificial light after darkness onset at night or abnormally prolonging the light period confuses the master circadian pacemaker, that is, the SCN, and also all downstream oscillators throughout the organism. The SCN, over eons of evolution, have been accustomed to responding to a single period of light and a single interval of darkness every 24 hours, which only change gradually over the seasons. This pattern has been severely corrupted by modern man due to the excessive use and misuse of artificial light at night. Indeed, the invention of the light bulb by Thomas Elva Edison in 1879 did the SCN a major disservice.
There are a number of obvious consequences of contaminating the night with light. Included in this group is sleep deprivation, 11, 12 circadian rhythm disruption, 13, 14 and nocturnal melatonin suppression. 15, 16 Each of these perturbations would reasonably be expected to affect the physiology of organisms and, in the worst-case scenarios, cause pathologies.
Within the past decade, the emphasis of research in this area has focused on cancer, most notably breast 17, 18 and prostate cancer, 19, 20 as possible pathophysiological processes resulting from repeated interruptions of the night with bright, wavelength-appropriate light. 21, 22 This brief review surveys the likely role of each of the resulting perturbations in terms of their potential contributions to the alleged rises in cancer risk. In the discussion that follows, each of the perturbations is considered as an independent entity. It is obvious, however, that there is extensive overlap and interactions among these, and in fact, the reported rise in cancer risk may well be a consequence of the combined actions of sleep inefficiency, chronodisruption, and melatonin suppression, that is, the negative health outcome has a multifactorial basis.
One of the most conspicuous and well-studied gross cycles that is altered in organisms that are exposed to sufficiently bright and wavelength-appropriate light during the daily period of darkness is that of pineal melatonin synthesis and secretion. 7 Pineal melatonin production as well as its levels in the blood are unwaveringly higher at night than during the day in all vertebrates regardless of their daily patterns of activity, that is, diurnal, nocturnal, or crepuscular. 23 As a result, this humoral message, which in effect is a physiological extension of the SCN, strengthens a variety of fundamental circadian cycles in all cells in the organism.
Sleep Duration and Cancer Risk
A number of studies have reported an inverse correlation between the frequency of cancer in the population and the duration of sleep; thus, in most studies an elevated cancer risk was associated with shorter sleep intervals. The first of these reports was published by Verkasalo et al, 24 who observed a higher incidence in breast cancer in Finnish women who slept an average ≤6 hours per night (assessed by self-administered questionnaire) versus those who regularly had long nightly sleep durations (≥9 hours). This outcome is consistent with the observations of Pinheiro et al 25 and Wu et al, 26 both of who also found an elevated breast cancer risk in US (Nurses' Health Study) and Chinese (in Singapore) women who were regularly short duration sleepers. More recently, Kakizaki and colleagues reported that both female breast cancer 27 and prostate cancer 28 were more common in the Japanese population (the Ohsaki Cohort Study) who were short duration sleepers.
In each of these reports, reduced melatonin availability due to the short periods of darkness was considered instrumental as a potential causative agent of the increased cancer risk. Although this assumption certainly has justification, there may be other viable explanations that could account for short sleep periods increasing the likelihood of cancer.
The act of sleeping has biological functions at the molecular level that supersede the actions on the biological clock. 29 Working exclusively with neural tissue, scientists at the Sleep and Respiratory Biology Institute in Philadelphia have identified 2000 genes that are either activated or turned off during sleep in mice. 30 What emerged from these studies is that the genes that are activated during sleep are concerned with generating essential molecules involved in basic aspects of cellular physiology. Moreover, even short periods of sleep deprivation induced changes indicative of elevated cellular stress, which would be expected to alter the proliferative dynamics of cells. Subsequent investigations have extended these findings to nonneural tissues where sleep-mediated changes in gene expression are similar to those in the brain. 31 Whereas these studies are still in their infancy and the data are not compelling, Pack 32 has theorized that the molecular changes resulting from alterations in the sleep/wake cycle could relate to the elevated risk of breast and prostate cancer as reported by others.
Although a relative melatonin deficiency may be the most plausible current explanation for an association between short sleep duration and cancer risk, the data summarized above, as they continue to accumulate, may reveal processes unique to sleep itself that modify the likelihood of cancer initiation, promotion, and progression.
Circadian Disruption and Cancer Risk
The studies of Filipski and colleagues dramatically demonstrate how chronodisruption is capable of accelerating the growth of transplanted tumors in animals. In their initial study, Filipski and Delauney 33 injected Glasgow osteosarcoma cells into mice and then exposed the animals either to a stable 12:12 light-dark cycle or to a 12:12 cycle that was phase advanced by 8 hours every 2 days. The 8-hour phase advance is equivalent to easterly flight from the central United States to Europe and presumably caused the mice to be in a constant state of jet lag. This repeatedly changed light-dark cycle likely severely reduced nocturnal melatonin levels (although these were not measured) as well as inducing chronodisruption. When tumor growth was compared in these 2 groups of mice, tumor cell proliferation as indicated by the more rapid increase in the size of the transplanted cancer was accelerated in the jet-lagged mice compared with those in the control group.
In a second study, Filipski and Li 34 electrolytically lesioned the biological clock, the SCN, in mice implanted with tumor cells. The loss of the SCN destroys circadian rhythmicity and likewise totally negates the nocturnal elevation of melatonin synthesis and secretion by the pineal gland (although in this study melatonin was again not measured). This destruction of the biological clock, as in the repeated phase shifting study, caused an accelerated growth of the injected tumor cells.
The studies of Filipski and coworkers 33, 34 do not distinguish which factor, that is, chronodisruption or melatonin suppression, actually led to the enhanced tumor growth. It seems likely, however, that both changes may have been contributory.
A connection between circadian disruption and cancer risk in humans has been suggested and is well supported by work in rodents. 35 The Per2 gene is an essential component of the circadian clock mechanisms in mammals. In Per2 mutant mice, the normal circadian cycle of 24 to 25 hours is appreciably shortened. Over time, these mutant mice prematurely develop tumors, and a significant percentage of the cancer-prone animals die by 16 months of age, many from spontaneous lymphoma. 2 This compares with a normal survival of nonmutant mice of 20 months of age. The mutant animals also exhibit an elevated sensitivity to g-radiation, again as indicated by an increased rate of tumor formation and also earlier hair graying and loss; the former response was likely a result of reduced cell death, which is normally a consequence of apoptosis in response to g-radiation.
Fu and coworkers 36 further showed that the expression of several key clock genes was markedly upregulated by g-radiation exposure in normal, but not in the Per2 mutant, mice. In particular, the expression of the cell growth gene, c-Myc, was found to have a circadian rhythm in wildtype liver but this rhythm was shifted and markedly upregulated in the liver of mutant mice. The key action of inactivating Per2 was, therefore, proposed to be the upregulation (derepression) of the c-Myc gene leading to accelerated cell growth and tumor formation. Normally, g-radiation upregulates clock genes such as Per2, which then leads to c-Myc repression. In the mutant mice, however, the upregulation of Per2 did not occur in response to radiation, so c-Myc exhibited a robust increase.
Melatonin Suppression and Cancer Risk
The most frequently espoused hypothesis to explain the elevated cancer risk in individuals exposed to what is commonly referred to as abnormal or severely altered photoperiodic environments is that light at night, that is, light pollution, causes melatonin suppression, which, in turn, exaggerates the initiation, promotion, 3,7,37-39 and progression of cancer growth. Certainly, that melatonin is an endogenously produced oncostatic agent has a large amount of experimental support. [40] [41] [42] [43] Moreover, there are a remarkably large number of either proposed and/or documented mechanisms to explain how melatonin achieves its cancer inhibitory effects (Figure 1 ). These mechanisms range widely from membrane receptormediated actions of melatonin on growth factor uptake 44, 45 to epigenetic modulation of cancer growth. 46 There is vast literature substantiating the ability of melatonin to not only limit the growth of already established tumors 40, 42, 43, [48] [49] [50] but also to prevent free radical-mediated damage to nuclear DNA; 51,52 thus, melatonin not only forestalls the promotion and progression of tumor growth but also may prevent tumor initiation by limiting the initial event, that is, DNA damage, that precedes the mutation necessary for tumor development. These data are supported by the general observations that aging is associated with a gradual decline in endogenous melatonin production, 53, 54 whereas the incidence of cancer increases. There is no definitive proof, however, that the loss of melatonin in advanced age is responsible for the increased cancer frequency. What is known is that the exposure of humans to light after darkness onset is capable of reducing blood concentrations of the oncostatic agent, melatonin. Such reductions in melatonin likely occur in night workers, 55, 56 in humans experiencing jet lag, 57, 58 and in presumably in individuals living in environments where they are exposed to excessive sky brightness resulting from light pollution due to the widespread use of artificial light.
When human tumor cells are transplanted into nude rats or mice (immune-compromised animals), the hastened growth of the cancer cells could be a consequence of reduced immune surveillance. In line with this, one obvious mechanism whereby melatonin may limit the growth of cancer cells in these immune-compromised animals may be via an upregulation of the immune system; certainly, a well-documented function of melatonin is its stimulatory effect on the immune function. This aspect of melatonin's functional repertoire has been commonly overlooked in studies (experimental and epidemiological) where circadian disruption, sleep deprivation, and/or melatonin suppression have been considered in relation to cancer risk or tumor cell growth. Each of the described parameters is reported to weaken immune surveillance.
Think Beyond Cancer
If, in fact, circadian disruption is definitively proven to be a significant factor in cancer risk, 59 it would seem unusual that carcinogenesis would be the only disease aggravated by severe alterations in the light-dark environment. While the current epidemic of obesity, in both children and adults, has been proposed to be a result of a variety of conditions (some of which have been seriously questioned as being contributory), for example, fat/carbohydrate-rich diets, inadequate exercise, plasticizers (phthalates), toxic endocrine-disrupting chemicals (the so-called obesogens, eg, bisphenol A or BPA, atrazine, tributylin, etc), perturbations in the light-dark cycle and altered sleep habits are not yet routinely invoked as potential causative factors. This possibility should be considered in light of several published reports. Qin et al 60 demonstrated that repeated alterations in circadian endocrine rhythms due to chronic nocturnal activity was associated with an elevated incidence of obesity and diabetes in humans. Moreover, Turek and colleagues 61 have shown a link between circadian Clock disturbances and obesity in mice. They reported that Clock mutant mice develop hyperphagia, become obese, and exhibit characteristics of the metabolic syndrome. Other aspects of fat cell biology also argue for a role of circadian rhythms and melatonin as regulators of obesity. Besides obesity and metabolic syndrome, these findings may have implications for the increase frequency of both type 1 and type 2 diabetes and associated metabolic disorders as well. [62] [63] [64] [65] [66] Considering the marked photoperiodic alterations experienced by children during this critical developmental period, the rises in attention deficit hyperactivity disorder and autism should be examined relative to perturbations of the light-dark environment as well. Both these conditions have tentatively been shown to improve with melatonin treatment. 67, 68 Finally, circadian rhythm disorders are believed to contribute to a variety of psychological disturbances, whereas melatonin treatment may be beneficial in some of these disorders. 69, 70 These are only a few of the many conditions that should be reexamined in reference to chronodisruption resulting from chronic unusual and/or nocturnal light exposure.
Concluding Remarks
Although evidence that excessive nighttime light exposure contributes in a significant manner to an elevated cancer risk is compelling, proof of an association is not yet definitive. Well-controlled experimental and clinical studies are still required before that alleged association will go unchallenged. What is encouraging is the substantial number of experimental findings that provide potential plausible explanations for light at night participating in the processes of oncogenesis. Among these, light-mediated melatonin suppression is often invoked as a contributory factor, and considering the plethora of data supporting this idea, this is a reasonable supposition. On the other hand, melatonin suppression alone may be too simplistic an explanation considering the multitude of pathophysiological molecular consequences that have been found to also accompany sleep disturbances (deprivation) and chronodisruption. Thus, whereas the expedited cellular proliferation could be an exclusive result of circadian disruption, sleep deprivation, or altered melatonin cycles (in terms of its amplitude or duration), it is more likely that accelerated cancer cell growth is a result of a combination of these factors and possibly others that have yet to be identified. Within the context of this brief summary, the concepts mentioned could not be fully developed. The interested reader should explore the original (cited and uncited) literature to get a more thorough understanding of this perplexing and complex issue.
Because of the findings summarized in the current report, in a recent theoretical review Alpert et al 71 suggested that wearing amber glasses (to filter the critical wavelengths of light that inhibit melatonin production) or using light bulbs that are free of those specific visual wavelengths of light (roughly 460-480 nm) may overcome the "toxic" effect of rampant light pollution and assist in limiting breast and prostate cancer incidence. Although some form of light hygiene 72 should be taken into consideration to assist in possibly reducing cancer risk that may be a result of excessive light exposure, only limiting the critical melatonin-inhibiting wavelengths from the visible spectrum may not in itself rectify the problem. One reason is that light is not the exclusive Zeitgeber for the biological clock. Likewise, food intake at unusual times (as occurs in shift workers) may 73 or may not serve a timesetting function for the SCN. Likewise, physical and psychological stress as well as exercise under some conditions may function as at least a modest Zeitgeber for the central pacemaker. Thus, whereas the suggestion of Alpert et al 71 is worthy of some consideration, the approach to solving this potential problem will likely be highly complex and require more than reducing exposure to the blue light wavelengths that serve as the necessary excitatory input to the specialized retinal photoreceptor (melanopsin-containing ganglion cells) that are in the chain of neurons that mediate light inhibition of pineal melatonin synthesis.
